Literature DB >> 11567822

Dislocation of small bowel volume within box pelvic treatment fields, using new "up down table" device.

C Capirci1, C Polico, G Mandoliti.   

Abstract

PURPOSE: To present the impact of a novel minimization device, the up down table (UDT), on the volume of small bowel included within a 4-field pelvic irradiation plan.
METHODS: A polystyrene bowel displacement standard mold was created and added to a customized vacuum cushion (Vac Lok) formed around the abdomen and legs of each patient in the prone position. Two hundred seventy-seven consecutive patients with pelvic malignancies treated with the UDT device were compared with 1 historic series (68 cases) treated at our division. Small bowel contrast dyes at the time of simulation were used in all patients.
RESULTS: The average volume of small bowel within the planning target volume (high-dose volume, calculated with Gallagher method) was 100 cm(3) (median 49 +/- 114) in the series treated with standard box technique and 23 cm(3) (median 0 +/- 64) in the series treated with the UDT (p < 0.001). The average volume of small bowel included in any isodose (any-dose volume) was 505 cm(3) (median 447 +/- 338) and 158 cm(3) (median 69 +/- 207), respectively (p < 0.001). The incidence of G1, G2, and G3 acute enteric toxicity (Radiation Therapy Oncology Group criteria) in the UDT series was 16%, 15%, and 1.5%; in the standard box technique, it was 28%, 25%, and 3%, respectively (p < 0.05). The incidence of acute enteric toxicity directly correlated with the irradiated small bowel volume. In the UDT series, the 5-year actuarial incidence of G3 chronic enteric toxicity was 1.8%. The setup procedures, analyzed in 18 cases, revealed no systematic errors and a standard deviation equal to +/-5 mm for random errors.
CONCLUSIONS: The UDT technique is comfortable, inexpensive, highly reproducible, and permits an almost full bowel displacement from standard radiotherapy fields.

Entities:  

Mesh:

Year:  2001        PMID: 11567822     DOI: 10.1016/s0360-3016(01)01644-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.

Authors:  Anna Margherita Maffione; Alice Ferretti; Gaia Grassetto; Elena Bellan; Carlo Capirci; Sotirios Chondrogiannis; Marcello Gava; Maria Cristina Marzola; Lucia Rampin; Claudia Bondesan; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-16       Impact factor: 9.236

2.  Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Authors:  Carlo Capirci; Lucia Rampin; Paola A Erba; Fabrizio Galeotti; Giorgio Crepaldi; Elena Banti; Marcello Gava; Stefano Fanti; Giuliano Mariani; Pier Carlo Muzzio; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-15       Impact factor: 9.236

Review 3.  Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

Authors:  Theresa A Lawrie; John T Green; Mark Beresford; Linda Wedlake; Sorrel Burden; Susan E Davidson; Simon Lal; Caroline C Henson; H Jervoise N Andreyev
Journal:  Cochrane Database Syst Rev       Date:  2018-01-23

4.  EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis.

Authors:  Rosa Autorino; Luca Tagliaferri; Maura Campitelli; Daniela Smaniotto; Alessia Nardangeli; Gian Carlo Mattiucci; Gabriella Macchia; Benedetta Gui; Maura Miccò; Floriana Mascilini; Gabriella Ferrandina; Gyorgy Kovacs; Vincenzo Valentini; Maria Antonietta Gambacorta
Journal:  J Contemp Brachytherapy       Date:  2018-08-31

5.  Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up.

Authors:  Maria Antonietta Gambacorta; Antonino De Paoli; Marco Lupattelli; Giuditta Chiloiro; Angela Pia Solazzo; Brunella Barbaro; Sergio Alfieri; Fabio Maria Vecchio; Jacopo Lenkowicz; Francesco Navarria; Elisa Palazzari; Giulio Bertola; Alessandro Frattegiani; Bruce Minsky; Vincenzo Valentini
Journal:  Clin Transl Radiat Oncol       Date:  2018-03-17

6.  Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial.

Authors:  Giovanna Mantini; Sergio Fersino; Anna Rita Alitto; Vincenzo Frascino; Mariangela Massaccesi; Bruno Fionda; Vincenzo Iorio; Stefano Luzi; Mario Balducci; Gian Carlo Mattiucci; Francesco Di Nardo; Antonio De Belvis; Alessio Giuseppe Morganti; Vincenzo Valentini
Journal:  Biomed Res Int       Date:  2014-06-30       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.